Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
Hall MD, Mittauer KE, Herrera R, Von Werne K, Kotecha R, Kalman NS, McCulloch J, Alvarez D, McAllister NC, Doty DG, Rzepczynski AE, Deere W, Gutierrez AN, Chuong MD. Hall MD, et al. Among authors: kalman ns. Front Oncol. 2023 Jan 11;12:1037674. doi: 10.3389/fonc.2022.1037674. eCollection 2022. Front Oncol. 2023. PMID: 36713501 Free PMC article.
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.
Ledesma Vicioso N, Lin D, Gomez DR, Yang JT, Lee NY, Rimner A, Yamada Y, Zelefsky MJ, Kalman NS, Rutter CE, Kotecha RR, Mehta MP, Panoff JE, Chuong MD, Salner AL, Ostroff JS, Diamond LC, Mathis NJ, Cahlon O, Pfister DG, Zhang Z, Chino F, Tsai J, Gillespie EF. Ledesma Vicioso N, et al. Among authors: kalman ns. JCO Oncol Pract. 2022 May;18(5):e780-e785. doi: 10.1200/OP.22.00037. JCO Oncol Pract. 2022. PMID: 35544650 Free PMC article.
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases.
Kutuk T, Herrera R, Mustafayev TZ, Gungor G, Ugurluer G, Atalar B, Kotecha R, Hall MD, Rubens M, Mittauer KE, Contreras JA, McCulloch J, Kalman NS, Alvarez D, Romaguera T, Gutierrez AN, Garcia J, Kaiser A, Mehta MP, Ozyar E, Chuong MD. Kutuk T, et al. Among authors: kalman ns. Adv Radiat Oncol. 2022 Apr 25;7(6):100978. doi: 10.1016/j.adro.2022.100978. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 35647412 Free PMC article.
30 results